ImmunityBio (IBRX) Total Debt Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 6.94% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | 50.25% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.07% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | 18.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.07% |
| Sep 30, 2025 | -5.39% |
| Jun 30, 2025 | -0.59% |
| Mar 31, 2025 | -1.44% |
| Sep 30, 2024 | -4.27% |
| Jun 30, 2024 | -5.99% |
| Mar 31, 2024 | -19.66% |
| Dec 31, 2023 | -16.73% |
| Sep 30, 2023 | 110.65% |
| Mar 31, 2023 | 560.36% |
| Sep 30, 2022 | 654.82% |
| Jun 30, 2022 | 588.65% |
| Mar 31, 2022 | 486.85% |
| Sep 30, 2021 | 423.44% |
| Jun 30, 2021 | 459.88% |
| Mar 31, 2021 | 404.36% |
| Dec 31, 2020 | 384.77% |
| Sep 30, 2020 | 195.71% |
| Mar 31, 2020 | -26.22% |
| Dec 31, 2019 | -34.79% |
| Sep 30, 2019 | -22.34% |
| Jun 30, 2019 | -17.86% |
| Mar 31, 2019 | -2.93% |
| Dec 31, 2018 | 7.85% |
| Sep 30, 2018 | 52.77% |
| Jun 30, 2018 | 212.82% |
| Dec 31, 2017 | 137.23% |